Charting the new era of proteomics
Erisyon Inc. is commercializing the world’s first single molecule protein sequencer that promises to transform the way we detect, treat, and track disease. Inheriting over a decade of work performed at the University of Texas at Austin's Center for Systems and Synthetic Biology, Erisyon was founded in March 2018 by a group of technologists and entrepreneurs with the ambition to usher in new discoveries that make the world healthier, safer, and more abundant.
Papers and Reference Literature
–ACS Chemical Biology
–PLOS Computational Biology
–Royal Society of Chemistry